Navigation Links
Zebrafish research meeting to highlight advances in genetics and developmental biology
Date:6/20/2014

BETHESDA, MD Nearly 900 scientists from 27 countries will attend the 11th International Conference on Zebrafish Development and Genetics organized by the Genetics Society of America (GSA), June 2428, 2014, in Madison, Wisconsin. The conference will feature 600 presentations of cutting-edge research results on topics including embryonic and adult development, functional genomics, regenerative medicine, chemical biology, emerging technologies, evolution, and cancer as well as cardiovascular, digestive, and infectious diseases. In addition to the scientific programming, the GSA has organized several sessions designed to provide career development for the 60% of student and postdoctoral attendees; this includes a daylong pre-conference 'Trainee Bootcamp' that will provide guidance on obtaining research funding and pursuing careers within and beyond academia.

One of the highlights of the meeting will be the Chi-Bin Chien Award lecture on Thursday, June 26th, which is presented by an outstanding graduate student, postdoctoral trainee, or recently appointed faculty member. This award honors zebrafish researcher Dr. Chi-Bin Chien (19652011) and his enthusiasm for the discussion of scientific ideas and the synergistic ideas that arise from interactions and open conversation among researchers, his efforts to mentor and support young scientists, and the collaborative and generous spirit with which he contributed to advances in zebrafish research. The 2014 awardee and only the second recipient of this award is postdoc Andrea Pauli, PhD (Harvard University), who will speak about her work on developmental genomics: "From genomics to novel gene functions in zebrafish."

The zebrafish (Danio rerio) is a popular model organism for studying vertebrate development and genetics, because it is : 1) well-characterized at the molecular and behavioral levels, 2) practical to work with in a laboratory setting, 3) able to regenerate several of its organs, and 4) large and transparent during embryonic development. Because of its genetic similarity to humans, the zebrafish is also a common model for human disease and toxicity testing. As with other model organisms around which GSA organizes conferences, research using zebrafish has enabled breakthrough discoveries in genetics that have advanced our understanding of fundamental biology and provided valuable insights into human disease. The biennial conference brings together leading laboratories using this important organism, and will showcase some of the latest significant developments in genetics research.


'/>"/>

Contact: Raeka Aiyar, Ph.D.
press@genetics-gsa.org
202-412-1120
Genetics Society of America
Source:Eurekalert

Related medicine news :

1. Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment
2. Zebrafish reveal promising mechanism for healing spinal cord injury
3. Tension on gut muscles induces cell invasion in zebrafish intestine, mimicking cancer metastasis
4. Individual gene differences can be tested in zebrafish
5. The zebrafish revealed a central regulator for the development of the brain histamine system
6. Family ties: Relationship between human and zebrafish genomes
7. For first time, drug developed based on zebrafish studies passes Phase I clinical trial
8. Zebrafish discovery may shed light on human kidney function
9. Purification, culture and multi-lineage differentiation of zebrafish neural crest cells
10. Variable gene expression in zebrafish
11. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... ZyDoc , ... Processing–Enabled and Conventional Data Capture Methods for Input to Electronic Health Records: A ... Results of the comparative usability study demonstrate that a dictation-based method (“NLP Entry”) ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... David ... with global law firm Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, ... of the DeviceTalks series, and attorneys from the firm’s global Life Sciences & Medical ...
(Date:12/8/2016)... ... December 08, 2016 , ... STATEN ISLAND, ... recognized for adherence to the highest standards of trauma, maternity, cancer and chronic ... center's president and CEO, Dr. Daniel Messina. , Among the recognitions, the American ...
(Date:12/8/2016)... ... ... Vida Health, the digital health platform that pairs individuals with ... . Other investors include Nokia Growth Partners (NGP) and returning investor Aspect Ventures. Vida ... are managing chronic conditions or simply want to improve their health. Canvas ...
(Date:12/8/2016)... ... ... Coppin Insurance Agency, an insurance and financial planning firm based in Lee ... is embarking on a charity drive with the goal of providing support and donations ... Bank of Southwest Florida works to provide fresh and nutritious food free of charge ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016  Eli Lilly and Company ... of its phase 3 EXPEDITION3 trial at the 9 ... As previously disclosed, solanezumab did not meet the primary ... solanezumab initiated in people with mild dementia due to ... submissions for solanezumab for the treatment of mild dementia ...
(Date:12/8/2016)... QUEBEC CITY , Dec. 8, 2016 /PRNewswire/ ... key US patents for improving the accuracy, reproducibility ... CD images in long and small bone orthopaedic ... proprietary approach to creating personalized orthopaedic restorations based ... create personalized orthopaedic restorations, the company harnesses the ...
(Date:12/8/2016)... Dec. 8, 2016  EIP Pharma, LLC ( ... proof-of-mechanism for neflamapimod (previously code named VX-745), with ... clinical trials that demonstrated significant Alzheimer,s disease relevant ... treatment) and Study 303 (6-week treatment) are the ... Alzheimer,s Disease (CTAD) scientific conference in ...
Breaking Medicine Technology: